Product proliferation and a shift to value-based care are creating the need for radical change in the integrated delivery network pharmaceutical supply chain. This research details how supply chain leaders responsible for IDNs can align cost-efficient business strategies with patient-centered care.
Impacts and Recommendations
- Supply Chain Leaders' Limited Control Over Pharmacy Supply Chains Makes It Difficult to Synchronize the End-to-End Supply Chain
- Narrowly Focused Metrics Impact Supply Chain Leaders' Abilities to Make Trade-Off Decisions on Service, Cost and Patient Outcomes
- Define a Value-Driven Pharmaceutical Supply Chain
- Link Supply Chain Capabilities and Clinical Operations
- A 50% Growth in the Portfolio of Products Over the Past Three to Five Years Adds Complexity to the Pharmaceutical Supply Chain
Gartner Recommended Reading
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see
Guiding Principles on Independence and Objectivity.